|
Adeline Boulanger (Paul Frank + Collins P.C.)
|
|
Alberto Haddad (Mj & Cie)
|
|
Alexandra Suhas (Zedra Global Expansion Us)
|
|
Alexia Sibony (Mindmaze)
|
|
Anne Moulin (Domes Pharma Us Inc.)
|
|
Aude Ouensanga (Alira Health)
|
|
Bernard Malfroy-Camine (Mindset Rx)
|
|
Carin Knoop (Harvard Business School)
|
|
Catherine Chaulet (Global Dmc Partners)
|
|
Charlie Attlan (Boston Scientific)
|
|
Christophe Arbet-Engels (Millendo Therapeutics)
|
|
Delphine Zurkiya (Mckinsey)
|
|
Eric Pité (Posit)
|
|
Frederic Nicol (Takeda)
|
|
Helenn Lemaistre (Credit Mutuel Equity)
|
|
Herve Seux (Investor)
|
|
Jean-Charles Wirth (Milliporesigma (Merck Kgaa))
|
|
Jean-Jacques Yarmoff (Mmld)
|
|
Jean-Marc Peallat (Automation Engineering Inc)
|
|
Jean-Pierre Sommadossi (Atea Pharmaceuticals)
|
|
Joel Berniac (Biofuturis, Llc)
|
|
Linda Kassa Hote (Teamwork Us)
|
|
Loredana Vieil (Ernst & Young)
|
|
Nicolas De Beco (Quadient)
|
|
Patrick Millot (Laticrete)
|
|
Patrick Tricoli (Nanobiotix)
|
|
Philippe Gassin (Optics 1)
|
|
Philippe Lopes-Fernandes (Ipsen)
|
|
Philippe Mourere (Stilla Technologies)
|
|
Philippe Sauvage (Sanofi)
|
|
Philippe Suhas (Axelia Partners)
|
|
Pierre Matte (Stmicroelectronics)
|
|
Renaud Megard (Nfi Corp)
|
|
Romain Marmot (Aptar)
|
|
Thierry Bernard (Qiagen)
|
|
Valerie Philippon (Takeda)
|
|
Vincent Geffray (Everbridge)
|
|
Vincent Hennemand (Intergalactic Therapeutics)
|
|
Xavier Touret (Natixis)
|
|
Yannick Wittner (Dassault Systemes)
|
